Bio Green Med Solution Inc (BGMS) Stock Price, Quote & News

Company Profile

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Industry: Building Products & Equipment

Sector: Industrials

Phone: 60 9 08955 0526

Website: bgmsglobal.com

Address:

Level 10, Tower 11 Avenue 5, No. 8 Jalan Kerinchi, Kuala Lumpur, Malaysia

ShangVXO Aug. 18 at 2:25 PM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $JAGX and $BGMS getting my attention

0 · Reply

focafoca99 Aug. 14 at 10:23 AM

$BGMS issued its Q2 2026 results in a press release attached to the 8-K.

0 · Reply

bahjatbern Aug. 4 at 7:47 PM

$BGMS how can we join promoters list ? are you being paid on weekly basis or what target 😂

0 · Reply

JustBen47 Aug. 1 at 11:53 PM

$BGMS Shares surged more than 180% when the acquisition was announced and indicating investor enthusiasm for the transaction.

0 · Reply

Sw1ngb0t Jul. 22 at 10:37 PM

$BGMS the ticker that got me hooked last July... one year later and it's revvin up again

0 · Reply

Bullsarmy Jul. 16 at 10:51 PM

$BGMS Nice

0 · Reply

Sw1ngb0t Jul. 9 at 10:26 PM

$BGMS looks like a good spot here

0 · Reply

SaltWaterChickens Jul. 1 at 7:59 PM

$BGMS yup yup

0 · Reply

topstockalerts Jun. 29 at 10:06 PM

$BGMS the trend has a very natural feel to it.

0 · Reply

mightyshrimp Jun. 29 at 5:48 PM

$BGMS now only down 99.97%! Stoked!

0 · Reply

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Aug 12, 2026, 6:00 AM EDT - 7 days ago

Bio Green Med Solution Earnings release: Q2 2026

Aug 12, 2026, 6:00 AM EDT - 7 days ago

Bio Green Med Solution Quarterly report: Q2 2026

Jun 18, 2026, 12:30 PM EDT - 2 months ago

Bio Green Med Solution Transcript: AGM 2026

2026-06-05T13:28:48.000Z - 2 months ago

Why Is Penny Stock Bio Green Med Solution (BGMS) Up Today?

Jun 4, 2026, 4:10 PM EDT - 2 months ago

BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN.

May 14, 2026, 4:15 PM EDT - 3 months ago

BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 14, 2026, 4:00 PM EDT - 3 months ago

Bio Green Med Solution Earnings release: Q1 2026

May 14, 2026, 4:00 PM EDT - 3 months ago

Bio Green Med Solution Quarterly report: Q1 2026

May 1, 2026, 8:00 AM EDT - 3 months ago

Bio Green Med Solution Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Bio Green Med Solution Proxy statement: Proxy filing

Mar 30, 2026, 4:15 PM EDT - 5 months ago

BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Mar 30, 2026, 4:00 PM EDT - 5 months ago

Bio Green Med Solution Annual report: Q4 2025

Mar 30, 2026, 4:00 PM EDT - 5 months ago

Bio Green Med Solution Earnings release: Q4 2025

Nov 13, 2025, 4:40 PM EST - 9 months ago

Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update

Nov 13, 2025, 4:00 PM EST - 9 months ago

Bio Green Med Solution Quarterly report: Q3 2025

Nov 13, 2025, 4:00 PM EST - 9 months ago

Bio Green Med Solution Earnings release: Q3 2025

Aug 25, 2025, 8:00 AM EDT - 1 year ago

Bio Green Med Solution Proxy statement: Proxy Filing

Aug 13, 2025, 4:05 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Bio Green Med Solution Quarterly report: Q2 2025

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Bio Green Med Solution Earnings release: Q2 2025

Aug 4, 2025, 6:50 PM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

Jul 31, 2025, 8:00 AM EDT - 1 year ago

Bio Green Med Solution Registration statement: Registration Filing

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Bio Green Med Solution Registration statement: Registration Filing

Jul 7, 2025, 6:00 AM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

Jul 7, 2025, 6:00 AM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Jul 2, 2025, 9:00 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces Stock Split

Jun 25, 2025, 8:00 AM EDT - 1 year ago

Bio Green Med Solution Proxy statement: Proxy Filing

Jun 20, 2025, 4:30 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

Jun 3, 2025, 4:15 PM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

May 15, 2025, 12:50 AM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 15, 2025, 12:00 AM EDT - 1 year ago

Bio Green Med Solution Earnings release: Q1 2025

May 15, 2025, 12:00 AM EDT - 1 year ago

Bio Green Med Solution Quarterly report: Q1 2025

May 7, 2025, 9:00 AM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT

May 6, 2025, 6:00 AM EDT - 1 year ago

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN.

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Bio Green Med Solution Registration statement: Registration Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Bio Green Med Solution Proxy statement: Proxy Filing

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Apr 2, 2025, 4:00 PM EDT - 1 year ago

Bio Green Med Solution Annual report: Q4 2024

Apr 2, 2025, 4:00 PM EDT - 1 year ago

Bio Green Med Solution Earnings release: Q4 2024

Mar 24, 2025, 7:30 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock

Feb 27, 2025, 1:38 PM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

Jan 21, 2025, 7:00 AM EST - 1 year ago

Bio Green Med Solution Proxy statement: Proxy Filing

Jan 10, 2025, 7:00 AM EST - 1 year ago

Bio Green Med Solution Proxy statement: Proxy Filing

Jan 8, 2025, 7:00 AM EST - 1 year ago

Bio Green Med Solution Proxy statement: Proxy Filing

Jan 3, 2025, 9:01 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

Dec 5, 2024, 4:05 PM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs

Nov 14, 2024, 4:15 PM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

Nov 13, 2024, 12:22 PM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Nov 12, 2024, 4:45 PM EST - 1 year ago

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Nov 12, 2024, 12:00 AM EST - 1 year ago

Bio Green Med Solution Earnings release: Q3 2024

Nov 12, 2024, 12:00 AM EST - 1 year ago

Bio Green Med Solution Quarterly report: Q3 2024

Oct 28, 2024, 12:00 PM EDT - 1 year ago

Bio Green Med Solution Slides: Investor Presentation

Oct 24, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

Oct 23, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

Oct 9, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

Oct 9, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

Sep 25, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

Sep 9, 2024, 7:00 AM EDT - 2 years ago

Bio Green Med Solution Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 4, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 3, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Earnings release: Q2 2024

Aug 7, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results

Jun 26, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

Jun 4, 2024, 8:00 AM EDT - 2 years ago

Cyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

May 14, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Quarterly report: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Earnings release: Q1 2024

May 8, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

May 8, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Proxy statement: Proxy Filing

May 8, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Proxy statement: Proxy Filing

May 6, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

May 2, 2024, 4:30 PM EDT - 2 years ago

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

Apr 30, 2024, 7:00 AM EDT - 2 years ago

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

Apr 1, 2024, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer

Mar 22, 2024, 8:00 AM EDT - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

Mar 19, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Earnings Call Transcript: Q4 2023

Mar 19, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Annual report: Q4 2023

Mar 19, 2024, 4:30 PM EDT - 2 years ago

Bio Green Med Solution Earnings release: Q4 2023

Mar 19, 2024, 4:05 PM EDT - 2 years ago

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 13, 2024, 4:05 PM EDT - 2 years ago

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

Mar 7, 2024, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

Mar 6, 2024, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

Feb 20, 2024, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

Feb 8, 2024, 7:00 AM EST - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

Jan 30, 2024, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

Jan 19, 2024, 7:00 AM EST - 2 years ago

Bio Green Med Solution Registration statement: Registration Filing

Jan 8, 2024, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

Jan 2, 2024, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

Dec 22, 2023, 9:15 AM EST - 2 years ago

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

Dec 18, 2023, 9:00 AM EST - 2 years ago

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

Dec 12, 2023, 4:05 PM EST - 2 years ago

Cyclacel Pharmaceuticals Announces Reverse Stock Split

Nov 30, 2023, 9:15 AM EST - 2 years ago

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

Nov 28, 2023, 5:15 PM EST - 2 years ago

Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q

ShangVXO Aug. 18 at 2:25 PM

0 · Reply

focafoca99 Aug. 14 at 10:23 AM

$BGMS issued its Q2 2026 results in a press release attached to the 8-K.

0 · Reply

bahjatbern Aug. 4 at 7:47 PM

$BGMS how can we join promoters list ? are you being paid on weekly basis or what target 😂

0 · Reply

JustBen47 Aug. 1 at 11:53 PM

$BGMS Shares surged more than 180% when the acquisition was announced and indicating investor enthusiasm for the transaction.

0 · Reply

Sw1ngb0t Jul. 22 at 10:37 PM

$BGMS the ticker that got me hooked last July... one year later and it's revvin up again

0 · Reply

Bullsarmy Jul. 16 at 10:51 PM

$BGMS Nice

0 · Reply

Sw1ngb0t Jul. 9 at 10:26 PM

$BGMS looks like a good spot here

0 · Reply

SaltWaterChickens Jul. 1 at 7:59 PM

$BGMS yup yup

0 · Reply

topstockalerts Jun. 29 at 10:06 PM

$BGMS the trend has a very natural feel to it.

0 · Reply

mightyshrimp Jun. 29 at 5:48 PM

$BGMS now only down 99.97%! Stoked!

0 · Reply

Teigie Jun. 29 at 5:09 PM

$BGMS why is this going up? Not complaining though

0 · Reply

D_Young Jun. 25 at 6:06 PM

$BGMS How low can this go...???

2 · Reply

firedupinvestors Jun. 25 at 12:00 PM

$BGMS

0 · Reply

Sw1ngb0t Jun. 23 at 4:02 PM

$BGMS let's go for $10... long hold. crazy that the last spike pretty much happened in 1 minute

1 · Reply

Sw1ngb0t Jun. 23 at 2:08 PM

$BGMS did I nail the bottom? I thought that was folklore

0 · Reply

Sw1ngb0t Jun. 23 at 1:43 PM

$CRVO $BGMS $CLWT $CUPR using a new RSI / cumulative volume divergence signal that I really like. not necessarily done dropping

1 · Reply

Sw1ngb0t Jun. 23 at 1:37 PM

$BGMS 42% insider ownership

1 · Reply

Sw1ngb0t Jun. 23 at 1:22 PM

$BGMS in at 0.68...

0 · Reply

Sw1ngb0t Jun. 23 at 12:24 PM

$BGMS the extra little dip after the triple bottom? I like it either way

0 · Reply

BankingBig Jun. 22 at 3:03 PM

$BGMS loaded bunch of .71 here but also ready to dump under .70 if it can't pop out of this

0 · Reply

BankingBig Jun. 22 at 1:40 PM

$BGMS needs to rip out of this or we are in for a bloody mess.

0 · Reply

focafoca99 Jun. 22 at 10:28 AM

$BGMS approved the appointment of its auditor and re‑elected directors at its 2026 annual meeting.

0 · Reply

Market Cap	5.02M
Revenue (ttm)	750,000.00
Net Income (ttm)	-3.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-400.00%
Debt to Equity Ratio	0.00

Volume	7,600
Avg Vol	255,964
Day's Range	N/A - N/A
Shares Out	5.52M
Stochastic %K	25%
Beta	-0.38
Analysts	Hold
Price Target	N/A